FindTrial
Sign In

High Dose of Tacrolimus after Living-related Combined Liver-kidney Transplantation for a Chinese Adult with Primary Hyperoxaluria Type-1

High Dose of Tacrolimus after Living-related Combined Liver-kidney Transplantation for a Chinese Adult with Primary Hyperoxaluria Type-1

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR-RO-14004471
Enrollment
Unknown
Registered
2014-04-04
Start date
2013-06-05
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Living-related Combined Liver-kidney Transplantation

Interventions

1:Tacrolimus

Sponsors

People's Hospital of Zhengzhou
Lead Sponsor

Eligibility

Sex/Gender
Male
Age
20 Years to 20 Years

Inclusion criteria

Inclusion criteria: NA

Exclusion criteria

Exclusion criteria: NA

Design outcomes

Primary

MeasureTime frame
TDM;—

Countries

China

Contacts

Public ContactXiangguang Meng

Hepatic Surgery Center, People's Hospital of Zhengzhou

mxgmxgmxgmxgmxg@126.com+86 15237155968

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026